img

Global Molecular Targeted Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Molecular Targeted Therapy Market Insights, Forecast to 2034

Molecular-targeted therapy is a novel strategy born from our increasing understanding of the underlying pathways and key molecules involved in tumor growth and progression. Theoretically, the specificity of molecular targeted therapy should improve the therapeutic window by affecting the tumor cells and sparing normal cell.
Market Analysis and InsightsGlobal Molecular Targeted Therapy Market
Global Molecular Targeted Therapy market is expected to reach to US$ 146 million in 2023, with a positive growth of %, compared with US$ 139 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Molecular Targeted Therapy industry is evaluated to reach US$ 261.5 million in 2033. The CAGR will be 10.2% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Molecular Targeted Therapy market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Molecular Targeted Therapy market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Phoenix Molecular Designs
Prelude Therapeutics
Tempus
Bracco
iOmx Therapeutics
OncoDNA
Sapience Therapeutics
Caris Life Sciences
Hera Biolabs
CV6 Therapeutics
Carrick Therapeutics
Foundation Medicine
Cybrexa Therapeutics
Segment by Type
Monoclonal Antibodies
Small Molecule Inhibitors

Segment by Application


Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Molecular Targeted Therapy introduction, etc. Molecular Targeted Therapy Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Molecular Targeted Therapy
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Targeted Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecule Inhibitors
1.3 Market by Application
1.3.1 Global Molecular Targeted Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Colorectal Cancer
1.3.5 Leukemia
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Targeted Therapy Market Perspective (2018-2033)
2.2 Global Molecular Targeted Therapy Growth Trends by Region
2.2.1 Molecular Targeted Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Molecular Targeted Therapy Historic Market Size by Region (2018-2023)
2.2.3 Molecular Targeted Therapy Forecasted Market Size by Region (2024-2033)
2.3 Molecular Targeted Therapy Market Dynamics
2.3.1 Molecular Targeted Therapy Industry Trends
2.3.2 Molecular Targeted Therapy Market Drivers
2.3.3 Molecular Targeted Therapy Market Challenges
2.3.4 Molecular Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Molecular Targeted Therapy by Players
3.1.1 Global Molecular Targeted Therapy Revenue by Players (2018-2023)
3.1.2 Global Molecular Targeted Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Molecular Targeted Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Molecular Targeted Therapy Market Concentration Ratio
3.4.1 Global Molecular Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Targeted Therapy Revenue in 2022
3.5 Global Key Players of Molecular Targeted Therapy Head office and Area Served
3.6 Global Key Players of Molecular Targeted Therapy, Product and Application
3.7 Global Key Players of Molecular Targeted Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Targeted Therapy Breakdown Data by Type
4.1 Global Molecular Targeted Therapy Historic Market Size by Type (2018-2023)
4.2 Global Molecular Targeted Therapy Forecasted Market Size by Type (2024-2033)
5 Molecular Targeted Therapy Breakdown Data by Application
5.1 Global Molecular Targeted Therapy Historic Market Size by Application (2018-2023)
5.2 Global Molecular Targeted Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Molecular Targeted Therapy Market Size (2018-2033)
6.2 North America Molecular Targeted Therapy Market Size by Type
6.2.1 North America Molecular Targeted Therapy Market Size by Type (2018-2023)
6.2.2 North America Molecular Targeted Therapy Market Size by Type (2024-2033)
6.2.3 North America Molecular Targeted Therapy Market Share by Type (2018-2033)
6.3 North America Molecular Targeted Therapy Market Size by Application
6.3.1 North America Molecular Targeted Therapy Market Size by Application (2018-2023)
6.3.2 North America Molecular Targeted Therapy Market Size by Application (2024-2033)
6.3.3 North America Molecular Targeted Therapy Market Share by Application (2018-2033)
6.4 North America Molecular Targeted Therapy Market Size by Country
6.4.1 North America Molecular Targeted Therapy Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Molecular Targeted Therapy Market Size by Country (2018-2023)
6.4.3 North America Molecular Targeted Therapy Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Molecular Targeted Therapy Market Size (2018-2033)
7.2 Europe Molecular Targeted Therapy Market Size by Type
7.2.1 Europe Molecular Targeted Therapy Market Size by Type (2018-2023)
7.2.2 Europe Molecular Targeted Therapy Market Size by Type (2024-2033)
7.2.3 Europe Molecular Targeted Therapy Market Share by Type (2018-2033)
7.3 Europe Molecular Targeted Therapy Market Size by Application
7.3.1 Europe Molecular Targeted Therapy Market Size by Application (2018-2023)
7.3.2 Europe Molecular Targeted Therapy Market Size by Application (2024-2033)
7.3.3 Europe Molecular Targeted Therapy Market Share by Application (2018-2033)
7.4 Europe Molecular Targeted Therapy Market Size by Country
7.4.1 Europe Molecular Targeted Therapy Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Molecular Targeted Therapy Market Size by Country (2018-2023)
7.4.3 Europe Molecular Targeted Therapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Molecular Targeted Therapy Market Size (2018-2033)
8.2 China Molecular Targeted Therapy Market Size by Type
8.2.1 China Molecular Targeted Therapy Market Size by Type (2018-2023)
8.2.2 China Molecular Targeted Therapy Market Size by Type (2024-2033)
8.2.3 China Molecular Targeted Therapy Market Share by Type (2018-2033)
8.3 China Molecular Targeted Therapy Market Size by Application
8.3.1 China Molecular Targeted Therapy Market Size by Application (2018-2023)
8.3.2 China Molecular Targeted Therapy Market Size by Application (2024-2033)
8.3.3 China Molecular Targeted Therapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Molecular Targeted Therapy Market Size (2018-2033)
9.2 Asia Molecular Targeted Therapy Market Size by Type
9.2.1 Asia Molecular Targeted Therapy Market Size by Type (2018-2023)
9.2.2 Asia Molecular Targeted Therapy Market Size by Type (2024-2033)
9.2.3 Asia Molecular Targeted Therapy Market Share by Type (2018-2033)
9.3 Asia Molecular Targeted Therapy Market Size by Application
9.3.1 Asia Molecular Targeted Therapy Market Size by Application (2018-2023)
9.3.2 Asia Molecular Targeted Therapy Market Size by Application (2024-2033)
9.3.3 Asia Molecular Targeted Therapy Market Share by Application (2018-2033)
9.4 Asia Molecular Targeted Therapy Market Size by Region
9.4.1 Asia Molecular Targeted Therapy Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Molecular Targeted Therapy Market Size by Region (2018-2023)
9.4.3 Asia Molecular Targeted Therapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Molecular Targeted Therapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Molecular Targeted Therapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Phoenix Molecular Designs
11.1.1 Phoenix Molecular Designs Company Details
11.1.2 Phoenix Molecular Designs Business Overview
11.1.3 Phoenix Molecular Designs Molecular Targeted Therapy Introduction
11.1.4 Phoenix Molecular Designs Revenue in Molecular Targeted Therapy Business (2018-2023)
11.1.5 Phoenix Molecular Designs Recent Developments
11.2 Prelude Therapeutics
11.2.1 Prelude Therapeutics Company Details
11.2.2 Prelude Therapeutics Business Overview
11.2.3 Prelude Therapeutics Molecular Targeted Therapy Introduction
11.2.4 Prelude Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2023)
11.2.5 Prelude Therapeutics Recent Developments
11.3 Tempus
11.3.1 Tempus Company Details
11.3.2 Tempus Business Overview
11.3.3 Tempus Molecular Targeted Therapy Introduction
11.3.4 Tempus Revenue in Molecular Targeted Therapy Business (2018-2023)
11.3.5 Tempus Recent Developments
11.4 Bracco
11.4.1 Bracco Company Details
11.4.2 Bracco Business Overview
11.4.3 Bracco Molecular Targeted Therapy Introduction
11.4.4 Bracco Revenue in Molecular Targeted Therapy Business (2018-2023)
11.4.5 Bracco Recent Developments
11.5 iOmx Therapeutics
11.5.1 iOmx Therapeutics Company Details
11.5.2 iOmx Therapeutics Business Overview
11.5.3 iOmx Therapeutics Molecular Targeted Therapy Introduction
11.5.4 iOmx Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2023)
11.5.5 iOmx Therapeutics Recent Developments
11.6 OncoDNA
11.6.1 OncoDNA Company Details
11.6.2 OncoDNA Business Overview
11.6.3 OncoDNA Molecular Targeted Therapy Introduction
11.6.4 OncoDNA Revenue in Molecular Targeted Therapy Business (2018-2023)
11.6.5 OncoDNA Recent Developments
11.7 Sapience Therapeutics
11.7.1 Sapience Therapeutics Company Details
11.7.2 Sapience Therapeutics Business Overview
11.7.3 Sapience Therapeutics Molecular Targeted Therapy Introduction
11.7.4 Sapience Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2023)
11.7.5 Sapience Therapeutics Recent Developments
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Details
11.8.2 Caris Life Sciences Business Overview
11.8.3 Caris Life Sciences Molecular Targeted Therapy Introduction
11.8.4 Caris Life Sciences Revenue in Molecular Targeted Therapy Business (2018-2023)
11.8.5 Caris Life Sciences Recent Developments
11.9 Hera Biolabs
11.9.1 Hera Biolabs Company Details
11.9.2 Hera Biolabs Business Overview
11.9.3 Hera Biolabs Molecular Targeted Therapy Introduction
11.9.4 Hera Biolabs Revenue in Molecular Targeted Therapy Business (2018-2023)
11.9.5 Hera Biolabs Recent Developments
11.10 CV6 Therapeutics
11.10.1 CV6 Therapeutics Company Details
11.10.2 CV6 Therapeutics Business Overview
11.10.3 CV6 Therapeutics Molecular Targeted Therapy Introduction
11.10.4 CV6 Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2023)
11.10.5 CV6 Therapeutics Recent Developments
11.11 Carrick Therapeutics
11.11.1 Carrick Therapeutics Company Details
11.11.2 Carrick Therapeutics Business Overview
11.11.3 Carrick Therapeutics Molecular Targeted Therapy Introduction
11.11.4 Carrick Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2023)
11.11.5 Carrick Therapeutics Recent Developments
11.12 Foundation Medicine
11.12.1 Foundation Medicine Company Details
11.12.2 Foundation Medicine Business Overview
11.12.3 Foundation Medicine Molecular Targeted Therapy Introduction
11.12.4 Foundation Medicine Revenue in Molecular Targeted Therapy Business (2018-2023)
11.12.5 Foundation Medicine Recent Developments
11.13 Cybrexa Therapeutics
11.13.1 Cybrexa Therapeutics Company Details
11.13.2 Cybrexa Therapeutics Business Overview
11.13.3 Cybrexa Therapeutics Molecular Targeted Therapy Introduction
11.13.4 Cybrexa Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2023)
11.13.5 Cybrexa Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Molecular Targeted Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Small Molecule Inhibitors
Table 4. Global Molecular Targeted Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Molecular Targeted Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Molecular Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Molecular Targeted Therapy Market Share by Region (2018-2023)
Table 8. Global Molecular Targeted Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Molecular Targeted Therapy Market Share by Region (2024-2033)
Table 10. Molecular Targeted Therapy Market Trends
Table 11. Molecular Targeted Therapy Market Drivers
Table 12. Molecular Targeted Therapy Market Challenges
Table 13. Molecular Targeted Therapy Market Restraints
Table 14. Global Molecular Targeted Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Molecular Targeted Therapy Revenue Share by Players (2018-2023)
Table 16. Global Top Molecular Targeted Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Targeted Therapy as of 2022)
Table 17. Global Molecular Targeted Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Molecular Targeted Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Molecular Targeted Therapy, Headquarters and Area Served
Table 20. Global Key Players of Molecular Targeted Therapy, Product and Application
Table 21. Global Key Players of Molecular Targeted Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Molecular Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Molecular Targeted Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Molecular Targeted Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Molecular Targeted Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global Molecular Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Molecular Targeted Therapy Revenue Share by Application (2018-2023)
Table 29. Global Molecular Targeted Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Molecular Targeted Therapy Revenue Share by Application (2024-2033)
Table 31. North America Molecular Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Molecular Targeted Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Molecular Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Molecular Targeted Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Molecular Targeted Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Molecular Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Molecular Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Molecular Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Molecular Targeted Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Molecular Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Molecular Targeted Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Molecular Targeted Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Molecular Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Molecular Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Molecular Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Molecular Targeted Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Molecular Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Molecular Targeted Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Molecular Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Molecular Targeted Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Molecular Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Molecular Targeted Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Molecular Targeted Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Molecular Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Molecular Targeted Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Molecular Targeted Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 63. Phoenix Molecular Designs Company Details
Table 64. Phoenix Molecular Designs Business Overview
Table 65. Phoenix Molecular Designs Molecular Targeted Therapy Product
Table 66. Phoenix Molecular Designs Revenue in Molecular Targeted Therapy Business (2018-2023) & (US$ Million)
Table 67. Phoenix Molecular Designs Recent Developments
Table 68. Prelude Therapeutics Company Details
Table 69. Prelude Therapeutics Business Overview
Table 70. Prelude Therapeutics Molecular Targeted Therapy Product
Table 71. Prelude Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2023) & (US$ Million)
Table 72. Prelude Therapeutics Recent Developments
Table 73. Tempus Company Details
Table 74. Tempus Business Overview
Table 75. Tempus Molecular Targeted Therapy Product
Table 76. Tempus Revenue in Molecular Targeted Therapy Business (2018-2023) & (US$ Million)
Table 77. Tempus Recent Developments
Table 78. Bracco Company Details
Table 79. Bracco Business Overview
Table 80. Bracco Molecular Targeted Therapy Product
Table 81. Bracco Revenue in Molecular Targeted Therapy Business (2018-2023) & (US$ Million)
Table 82. Bracco Recent Developments
Table 83. iOmx Therapeutics Company Details
Table 84. iOmx Therapeutics Business Overview
Table 85. iOmx Therapeutics Molecular Targeted Therapy Product
Table 86. iOmx Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2023) & (US$ Million)
Table 87. iOmx Therapeutics Recent Developments
Table 88. OncoDNA Company Details
Table 89. OncoDNA Business Overview
Table 90. OncoDNA Molecular Targeted Therapy Product
Table 91. OncoDNA Revenue in Molecular Targeted Therapy Business (2018-2023) & (US$ Million)
Table 92. OncoDNA Recent Developments
Table 93. Sapience Therapeutics Company Details
Table 94. Sapience Therapeutics Business Overview
Table 95. Sapience Therapeutics Molecular Targeted Therapy Product
Table 96. Sapience Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2023) & (US$ Million)
Table 97. Sapience Therapeutics Recent Developments
Table 98. Caris Life Sciences Company Details
Table 99. Caris Life Sciences Business Overview
Table 100. Caris Life Sciences Molecular Targeted Therapy Product
Table 101. Caris Life Sciences Revenue in Molecular Targeted Therapy Business (2018-2023) & (US$ Million)
Table 102. Caris Life Sciences Recent Developments
Table 103. Hera Biolabs Company Details
Table 104. Hera Biolabs Business Overview
Table 105. Hera Biolabs Molecular Targeted Therapy Product
Table 106. Hera Biolabs Revenue in Molecular Targeted Therapy Business (2018-2023) & (US$ Million)
Table 107. Hera Biolabs Recent Developments
Table 108. CV6 Therapeutics Company Details
Table 109. CV6 Therapeutics Business Overview
Table 110. CV6 Therapeutics Molecular Targeted Therapy Product
Table 111. CV6 Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2023) & (US$ Million)
Table 112. CV6 Therapeutics Recent Developments
Table 113. Carrick Therapeutics Company Details
Table 114. Carrick Therapeutics Business Overview
Table 115. Carrick Therapeutics Molecular Targeted Therapy Product
Table 116. Carrick Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2023) & (US$ Million)
Table 117. Carrick Therapeutics Recent Developments
Table 118. Foundation Medicine Company Details
Table 119. Foundation Medicine Business Overview
Table 120. Foundation Medicine Molecular Targeted Therapy Product
Table 121. Foundation Medicine Revenue in Molecular Targeted Therapy Business (2018-2023) & (US$ Million)
Table 122. Foundation Medicine Recent Developments
Table 123. Cybrexa Therapeutics Company Details
Table 124. Cybrexa Therapeutics Business Overview
Table 125. Cybrexa Therapeutics Molecular Targeted Therapy Product
Table 126. Cybrexa Therapeutics Revenue in Molecular Targeted Therapy Business (2018-2023) & (US$ Million)
Table 127. Cybrexa Therapeutics Recent Developments
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Targeted Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Molecular Targeted Therapy Market Share by Type: 2022 VS 2033
Figure 3. Monoclonal Antibodies Features
Figure 4. Small Molecule Inhibitors Features
Figure 5. Global Molecular Targeted Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Molecular Targeted Therapy Market Share by Application: 2022 VS 2033
Figure 7. Lung Cancer Case Studies
Figure 8. Breast Cancer Case Studies
Figure 9. Colorectal Cancer Case Studies
Figure 10. Leukemia Case Studies
Figure 11. Others Case Studies
Figure 12. Molecular Targeted Therapy Report Years Considered
Figure 13. Global Molecular Targeted Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Molecular Targeted Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Molecular Targeted Therapy Market Share by Region: 2022 VS 2033
Figure 16. Global Molecular Targeted Therapy Market Share by Players in 2022
Figure 17. Global Top Molecular Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Targeted Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Molecular Targeted Therapy Revenue in 2022
Figure 19. North America Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Molecular Targeted Therapy Market Share by Type (2018-2033)
Figure 21. North America Molecular Targeted Therapy Market Share by Application (2018-2033)
Figure 22. North America Molecular Targeted Therapy Market Share by Country (2018-2033)
Figure 23. United States Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Molecular Targeted Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Molecular Targeted Therapy Market Share by Type (2018-2033)
Figure 27. Europe Molecular Targeted Therapy Market Share by Application (2018-2033)
Figure 28. Europe Molecular Targeted Therapy Market Share by Country (2018-2033)
Figure 29. Germany Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Molecular Targeted Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Molecular Targeted Therapy Market Share by Type (2018-2033)
Figure 37. China Molecular Targeted Therapy Market Share by Application (2018-2033)
Figure 38. Asia Molecular Targeted Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Molecular Targeted Therapy Market Share by Type (2018-2033)
Figure 40. Asia Molecular Targeted Therapy Market Share by Application (2018-2033)
Figure 41. Asia Molecular Targeted Therapy Market Share by Region (2018-2033)
Figure 42. Japan Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Molecular Targeted Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Molecular Targeted Therapy Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Molecular Targeted Therapy Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Molecular Targeted Therapy Market Share by Country (2018-2033)
Figure 52. Brazil Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Molecular Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Phoenix Molecular Designs Revenue Growth Rate in Molecular Targeted Therapy Business (2018-2023)
Figure 59. Prelude Therapeutics Revenue Growth Rate in Molecular Targeted Therapy Business (2018-2023)
Figure 60. Tempus Revenue Growth Rate in Molecular Targeted Therapy Business (2018-2023)
Figure 61. Bracco Revenue Growth Rate in Molecular Targeted Therapy Business (2018-2023)
Figure 62. iOmx Therapeutics Revenue Growth Rate in Molecular Targeted Therapy Business (2018-2023)
Figure 63. OncoDNA Revenue Growth Rate in Molecular Targeted Therapy Business (2018-2023)
Figure 64. Sapience Therapeutics Revenue Growth Rate in Molecular Targeted Therapy Business (2018-2023)
Figure 65. Caris Life Sciences Revenue Growth Rate in Molecular Targeted Therapy Business (2018-2023)
Figure 66. Hera Biolabs Revenue Growth Rate in Molecular Targeted Therapy Business (2018-2023)
Figure 67. CV6 Therapeutics Revenue Growth Rate in Molecular Targeted Therapy Business (2018-2023)
Figure 68. Carrick Therapeutics Revenue Growth Rate in Molecular Targeted Therapy Business (2018-2023)
Figure 69. Foundation Medicine Revenue Growth Rate in Molecular Targeted Therapy Business (2018-2023)
Figure 70. Cybrexa Therapeutics Revenue Growth Rate in Molecular Targeted Therapy Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries